Building a biocontainment unit: Infrastructure and organizational experiences of the 13 regional biocontainment units in the United States - 30/12/24
, Corri B. Levine, PhD, MS, MPH b, Kara Marshall, MPH b, Sophia Shea, MPH c, Christa Arguinchona, MSN, BSN, CCRN d, Sharon Vanairsdale Carrasco, DNP, APRN, FAEN, FAAN, FNAP e, Lauren M. Sauer, MSc c, f, Jocelyn J. Herstein, PhD, MPH c, f
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Resumen |
In the United States, the system for special pathogen patient care incorporates a network of federally funded US biocontainment units that maintain operational readiness to care for patients afflicted by high-consequence infectious diseases (HCIDs). This network has expanded in number of facilities and in scope, serving as a regional resource for special pathogen preparedness. Lessons learned for maintaining these units are shared with the intent of informing new and existing biocontainment units.
El texto completo de este artículo está disponible en PDF.Highlights |
• | Rapid survey deployed for partner request on special pathogen preparedness. |
• | Promising practices shared by a network of biocontainment units. |
• | Space and staff require extensive support to be effective. |
• | Collaboration nationally and internationally enhances special pathogen preparedness. |
• | Sharing promising practices is necessary to learn and grow. |
Key Words : Special pathogens, High-consequence infectious diseases
Esquema
| Funding/support: NETEC is funded by the Administration for Strategic Preparedness and Response and Centers for Disease Control and Prevention (U3REP150549-0549A). RESPTCs are funded by the Administration for Strategic Preparedness and Response (EP-U3R-22-002). |
|
| Conflicts of interest: None to report. |
Vol 53 - N° 1
P. 150-153 - janvier 2025 Regresar al número
Artículo precedente
- Experiences when using different EHMR models: Implications for different designs and meeting user expectations
- Emily J. Haas, Mihili Edirisooriya, Rohan Fernando, Caitlin McClain, Margaret Sietsema, Adam Hornbeck, Paul Thurman, Sara Angelilli, Hope Waltenbaugh, Sricharan Chalikonda, Stella E. Hines
- Persistent methicillin-resistant Staphylococcus aureus (MRSA) nares test positivity during initial days of systemic antistaphylococcal antimicrobial therapy
- Maximillian S. Wu, Wesley Kufel, Scott Riddell, Jeff Steele, Elizabeth Asiago-Reddy
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.